| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000080 | Mitotic g1 phase | Affects phenotype | PMID:28035397 |
| GO:0000084 | Mitotic s phase | Affects phenotype | PMID:28035397; PMID:34822792; PMID:38503349; PMID:38563506 |
| GO:0000085 | Mitotic g2 phase | Affects phenotype | PMID:28035397 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Affects phenotype | PMID:34822792; PMID:38503349 |
| GO:0000423 | Mitophagy | Decreases phenotype | PMID:31690173 |
| GO:0001774 | Microglial cell activation | Affects phenotype | PMID:34018660 |
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:29115570 |
| GO:0001889 | Liver development | Increases phenotype | PMID:26660635 |
| GO:0002381 | Immunoglobulin production involved in immunoglobulin-mediated immune response | Affects phenotype | PMID:30643099 |
| GO:0002534 | Cytokine production involved in inflammatory response | Increases phenotype | PMID:34014775 |
| GO:0004104 | Cholinesterase activity | Increases phenotype | PMID:34058180 |
| GO:0004364 | Glutathione transferase activity | Affects phenotype | PMID:30844427; PMID:32445656; PMID:33314588; PMID:34058180 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:30738988 |
| GO:0004602 | Glutathione peroxidase activity | Affects phenotype | PMID:23339144; PMID:30844427; PMID:32445656; PMID:33314588; PMID:37415728 |
| GO:0004784 | Superoxide dismutase activity | Increases phenotype | PMID:23339144; PMID:30844427; PMID:30844427; PMID:38129942; PMID:32445656; PMID:33314588; PMID:37415728; PMID:38129942 |
| GO:0005391 | P-type sodium:potassium-exchanging transporter activity | Decreases phenotype | PMID:37598760 |
| GO:0005764 | Lysosome | Decreases phenotype | PMID:31690173 |
| GO:0006007 | Glucose catabolic process | Increases phenotype | PMID:2204694 |
| GO:0006171 | Camp biosynthetic process | Affects phenotype | PMID:31161640 |
| GO:0006468 | Protein phosphorylation | Increases phenotype | PMID:23628791 |
| GO:0006497 | Protein lipidation | Decreases phenotype | PMID:31690173 |
| GO:0006521 | Regulation of cellular amino acid metabolic process | Affects phenotype | PMID:30715528 |
| GO:0006576 | Biogenic amine metabolic process | Decreases phenotype | PMID:31560393 |
| GO:0006606 | Protein import into nucleus | Affects phenotype | PMID:31690173 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:30715528 |
| GO:0006749 | Glutathione metabolic process | Affects phenotype | PMID:33314588 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:23339144; PMID:30844427 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:24777576; PMID:30844427 |
| GO:0006812 | Monoatomic cation transport | Affects phenotype | PMID:32080757 |
| GO:0006825 | Copper ion transport | Affects phenotype | PMID:24614235 |
| GO:0006875 | Cellular metal ion homeostasis | Affects phenotype | PMID:35212737 |
| GO:0006878 | Cellular copper ion homeostasis | Affects phenotype | PMID:24614235 |
| GO:0006884 | Cell volume homeostasis | Affects phenotype | PMID:38563506 |
| GO:0006914 | Autophagy | Decreases phenotype | PMID:31690173 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:10721100; PMID:11392499; PMID:24777576; PMID:25027559; PMID:25791630; PMID:26419736; PMID:28035397; PMID:29115570; PMID:30951808; PMID:30991096; PMID:31161640; PMID:31676349; PMID:32659473; PMID:35690225; PMID:38503349 |
| GO:0006919 | Activation of cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:16168523 |
| GO:0006929 | Substrate-dependent cell migration | Increases phenotype | PMID:30592962 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:23339144; PMID:32574669 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:23628791 |
| GO:0007042 | Lysosomal lumen acidification | Decreases phenotype | PMID:31690173 |
| GO:0007190 | Activation of adenylate cyclase activity | Increases phenotype | PMID:2986305 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:32445656; PMID:34822792 |
| GO:0007608 | Sensory perception of smell | Decreases phenotype | PMID:26765332 |
| GO:0007610 | Behavior | Affects phenotype | PMID:26209874; PMID:33154986 |
| GO:0007612 | Learning | Decreases phenotype | PMID:20855239; PMID:20936744; PMID:20943219; PMID:37598760; PMID:38129942 |
| GO:0007613 | Memory | Increases phenotype | PMID:24972623; PMID:24972623; PMID:30844427; PMID:26209874; PMID:30090589; PMID:30844427; PMID:32659473; PMID:34058180; PMID:37415728; PMID:38129942 |
| GO:0007625 | Grooming behavior | Increases phenotype | PMID:34058180 |
| GO:0007626 | Locomotory behavior | Affects phenotype | PMID:32692843 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:30090589 |
| GO:0008217 | Regulation of blood pressure | Affects phenotype | PMID:21878420 |
| GO:0008219 | Cell death | Increases phenotype | PMID:1417959; PMID:21985864; PMID:23313730; PMID:32659473 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:22249857; PMID:22542671; PMID:22982731; PMID:24845367; PMID:25791630; PMID:29579278; PMID:32659473; PMID:34058180; PMID:38563506 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:26794142 |
| GO:0008361 | Regulation of cell size | Affects phenotype | PMID:25817889; PMID:32659473 |
| GO:0008542 | Visual learning | Decreases phenotype | PMID:24972623; PMID:24972623; PMID:30844427; PMID:30844427 |
| GO:0008610 | Lipid biosynthetic process | Increases phenotype | PMID:1324726 |
| GO:0008635 | Activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c | Increases phenotype | PMID:25416158 |
| GO:0010729 | Positive regulation of hydrogen peroxide biosynthetic process | Increases phenotype | PMID:27701121 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Decreases phenotype | PMID:25981801 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:23499988; PMID:25981801; PMID:30715528 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:23339144; PMID:30738988; PMID:30844427; PMID:32445656; PMID:33314588 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:23339144; PMID:30738988 |
| GO:0021759 | Globus pallidus development | Affects phenotype | PMID:27466214 |
| GO:0021772 | Olfactory bulb development | Decreases phenotype | PMID:26765332 |
| GO:0022008 | Neurogenesis | Decreases phenotype | PMID:25539664; PMID:25575534; PMID:29579278 |
| GO:0030168 | Platelet activation | Increases phenotype | PMID:30537864 |
| GO:0030182 | Neuron differentiation | Decreases phenotype | PMID:29579278 |
| GO:0030220 | Platelet formation | Decreases phenotype | PMID:31991237 |
| GO:0031143 | Pseudopodium | Increases phenotype | PMID:30537864 |
| GO:0031325 | Positive regulation of cellular metabolic process | Increases phenotype | PMID:23499988 |
| GO:0031987 | Locomotion involved in locomotory behavior | Decreases phenotype | PMID:34018660; PMID:37598760 |
| GO:0035176 | Social behavior | Decreases phenotype | PMID:28569757; PMID:29847083 |
| GO:0040018 | Positive regulation of multicellular organism growth | Decreases phenotype | PMID:29020610 |
| GO:0042133 | Neurotransmitter metabolic process | Affects phenotype | PMID:30715528 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:30090589 |
| GO:0042417 | Dopamine metabolic process | Affects phenotype | PMID:34590183 |
| GO:0042428 | Serotonin metabolic process | Affects phenotype | PMID:37598760 |
| GO:0042554 | Superoxide anion generation | Affects phenotype | PMID:31690173 |
| GO:0042632 | Cholesterol homeostasis | Affects phenotype | PMID:25867198 |
| GO:0042743 | Hydrogen peroxide metabolic process | Affects phenotype | PMID:33314588 |
| GO:0043525 | Positive regulation of neuron apoptotic process | Increases phenotype | PMID:16168523; PMID:25416158 |
| GO:0043971 | Histone h3-k18 acetylation | Increases phenotype | PMID:38129942 |
| GO:0044114 | Development of symbiont in host | Affects phenotype | PMID:28610994 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:28035397; PMID:29115570; PMID:29957541; PMID:31161640; PMID:31676349; PMID:32574669; PMID:34822792; PMID:35690225; PMID:38503349; PMID:38563506; PMID:38857675 |
| GO:0045023 | G0 to g1 transition | Affects phenotype | PMID:38503349; PMID:38563506 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:31690173 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:28962525 |
| GO:0045664 | Regulation of neuron differentiation | Affects phenotype | PMID:26794142 |
| GO:0045860 | Positive regulation of protein kinase activity | Increases phenotype | PMID:3527812 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:31690173 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:33314588 |
| GO:0046466 | Membrane lipid catabolic process | Affects phenotype | PMID:12525082; PMID:1417959 |
| GO:0046847 | Filopodium assembly | Increases phenotype | PMID:30592962 |
| GO:0048873 | Homeostasis of number of cells within a tissue | Affects phenotype | PMID:30991096 |
| GO:0048874 | Host-mediated regulation of intestinal microbiota composition | Affects phenotype | PMID:35037767 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Increases phenotype | PMID:23339144; PMID:30738988; PMID:30844427 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:32692843 |
| GO:0050769 | Positive regulation of neurogenesis | Increases phenotype | PMID:26794142 |
| GO:0050801 | Monoatomic ion homeostasis | Affects phenotype | PMID:30090589 |
| GO:0050890 | Cognition | Increases phenotype | PMID:16393669; PMID:20549838; PMID:20936744; PMID:20943219; PMID:26381693; PMID:29847083; PMID:26209874; PMID:27448389 |
| GO:0051092 | Positive regulation of nf-kappab transcription factor activity | Increases phenotype | PMID:32692843 |
| GO:0051402 | Neuron apoptotic process | Increases phenotype | PMID:32692843; PMID:34018660 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:31676349; PMID:31690173; PMID:38503349 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:29115570 |
| GO:0055065 | Metal ion homeostasis | Decreases phenotype | PMID:29452138 |
| GO:0055070 | Copper ion homeostasis | Affects phenotype | PMID:25575534 |
| GO:0055071 | Manganese ion homeostasis | Decreases phenotype | PMID:24804307; PMID:25575534; PMID:26660635; PMID:26967026; PMID:27592743; PMID:28860195; PMID:29020610; PMID:34590183; PMID:36152728; PMID:37022104 |
| GO:0060096 | Serotonin secretion, neurotransmission | Increases phenotype | PMID:31560393 |
| GO:0061526 | Acetylcholine secretion | Decreases phenotype | PMID:30738988 |
| GO:0061527 | Dopamine secretion, neurotransmission | Increases phenotype | PMID:31560393 |
| GO:0061533 | Norepinephrine secretion, neurotransmission | Increases phenotype | PMID:31560393 |
| GO:0061744 | Motor behavior | Increases phenotype | PMID:26209874; PMID:26381693; PMID:26968381; PMID:31560393; PMID:34896555 |
| GO:0061900 | Glial cell activation | Increases phenotype | PMID:32692843 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:32659473; PMID:38129942 |
| GO:0070509 | Calcium ion import | Increases phenotype | PMID:30951808 |
| GO:0070527 | Platelet aggregation | Increases phenotype | PMID:30537864 |
| GO:0070534 | Protein k63-linked ubiquitination | Increases phenotype | PMID:31690173 |
| GO:0070577 | Lysine-acetylated histone binding | Decreases phenotype | PMID:38129942 |
| GO:0070994 | Detection of oxidative stress | Affects phenotype | PMID:37415728; PMID:38129942; PMID:38857675 |
| GO:0070997 | Neuron death | Increases phenotype | PMID:25461191 |
| GO:0071421 | Manganese ion transmembrane transport | Affects phenotype | PMID:27681840; PMID:28860195; PMID:8549643 |
| GO:0071743 | Ige immunoglobulin complex, circulating | Affects phenotype | PMID:30643099 |
| GO:0071965 | Multicellular organismal locomotion | Decreases phenotype | PMID:29020610 |
| GO:0072378 | Blood coagulation, fibrin clot formation | Increases phenotype | PMID:30537864 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:23339144; PMID:25817889; PMID:28035397; PMID:34310962; PMID:38503349 |
| GO:0072673 | Lamellipodium morphogenesis | Increases phenotype | PMID:30592962 |
| GO:0090326 | Positive regulation of locomotion involved in locomotory behavior | Decreases phenotype | PMID:28610743 |
| GO:0097202 | Activation of cysteine-type endopeptidase activity | Increases phenotype | PMID:25841707; PMID:30738988 |
| GO:0097237 | Cellular response to toxic substance | Increases phenotype | PMID:23628791 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:32445656 |
| GO:0098711 | Iron ion import across plasma membrane | Increases phenotype | PMID:22898811 |
| GO:0098989 | Nmda selective glutamate receptor signaling pathway | Decreases phenotype | PMID:29205667 |
| GO:0140048 | Manganese ion export across plasma membrane | Increases phenotype | PMID:28860195 |
| GO:1901142 | Insulin metabolic process | Affects phenotype | PMID:25867198 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:28035397; PMID:34822792; PMID:38503349; PMID:38563506 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:30991096 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:28962525; PMID:32007923 |
| GO:1990834 | Response to odorant | Decreases phenotype | PMID:26765332 |
| GO:2000403 | Positive regulation of lymphocyte migration | Increases phenotype | PMID:36220500 |
| GO:2000872 | Positive regulation of progesterone secretion | Decreases phenotype | PMID:25981801 |
| GO:2001057 | Reactive nitrogen species metabolic process | Increases phenotype | PMID:25817889 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.